Caseware UK (AP4) 2023.0.135 2023.0.135 2024-06-302024-06-30No description of principal activity002023-01-01truefalsetruefalse 13937133 2023-01-01 2024-06-30 13937133 2022-02-24 2022-12-31 13937133 2024-06-30 13937133 2022-12-31 13937133 c:Director2 2023-01-01 2024-06-30 13937133 d:CurrentFinancialInstruments 2024-06-30 13937133 d:CurrentFinancialInstruments 2022-12-31 13937133 d:ShareCapital 2024-06-30 13937133 d:ShareCapital 2022-12-31 13937133 c:OrdinaryShareClass1 2023-01-01 2024-06-30 13937133 c:OrdinaryShareClass1 2024-06-30 13937133 c:OrdinaryShareClass1 2022-12-31 13937133 c:EntityHasNeverTraded 2023-01-01 2024-06-30 13937133 c:FRS102 2023-01-01 2024-06-30 13937133 c:AuditExempt-NoAccountantsReport 2023-01-01 2024-06-30 13937133 c:FullAccounts 2023-01-01 2024-06-30 13937133 c:PrivateLimitedCompanyLtd 2023-01-01 2024-06-30 13937133 e:PoundSterling 2023-01-01 2024-06-30 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 13937133








BRIGHTWALTON BLOODSTOCK LIMITED
(FORMERLY DUNMOORE DM LIMITED)



UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE PERIOD ENDED 30 JUNE 2024

 
BRIGHTWALTON BLOODSTOCK LIMITED
  
(FORMERLY DUNMOORE DM LIMITED)
REGISTERED NUMBER:13937133

BALANCE SHEET
AS AT 30 JUNE 2024

30 June
31 December
2024
2022
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 3 
1
1

  
1
1

Total assets less current liabilities
  
 
 
1
 
 
1

  

Net assets
  
1
1


Capital and reserves
  

Called up share capital 
 4 
1
1

  
1
1


For the period ended 30 June 2024 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




J R Hobby
Director

Date: 24 March 2025

The notes on page 2 form part of these financial statements.

Page 1

 
BRIGHTWALTON BLOODSTOCK LIMITED
 
(FORMERLY DUNMOORE DM LIMITED)
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2024

1.


General information

The company is limited by shares and is incorporated in England and Wales (registered number 13937133)  with a registered office at Brightwalton House, Brightwalton, Newbury, RG20 7BZ.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.


3.


Debtors

30 June
31 December
2024
2022
£
£


Called up share capital not paid
1
1

1
1



4.


Share capital

30 June
31 December
2024
2022
£
£
Allotted, called up and fully paid



1 (2022 - 1) Ordinary share of £1.00
1
1


Page 2